Chelatec – A Leading Preclinical CRO for Targeted Radionuclide Therapy

Time: 11:45 am
day: P&T Track AM

Details:

  • 20 + years in the radiopharmaceutical space
  • From radiolabeling to in vivo investigation
  • The way to IND application

Speakers: